West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter 2026

Published: 2026-04-23 08:24:00 ET WST

Published on 04/23/2026 at 08:24 am EDT

West Pharmaceutical Services, Inc. provided earnings guidance for the second quarter 2026. For the period, it is introducing its second-quarter 2026 net sales guidance range of $830 million to $850 million. Reported net sales growth anticipated to be in the range of 8.3% to 10.9%.